- Published on
Pathology-Infectious Agents and Cancer
I. Overall Prevalence:
A. Helicobacter pylori:
A. Schistosomiasis haematobium:
I. Overall Prevalence:
- Infections account for 16% of global cancer incidence. This varies significantly: 9% in developed countries and >20% in developing countries.
- Ubiquity and Latency: Most tumor viruses are widespread, but infection doesn't automatically lead to cancer. Tumor development takes many years post-infection.
- Multifactorial Carcinogenesis: Viral infection initiates carcinogenesis, but additional genetic, immunological, and environmental factors are crucial for tumor formation. Some viruses increase the risk of multiple cancers.
- Prevalence and Transmission: The most common sexually transmitted infection in developed countries, spread through unprotected sex or contact with infected areas.
- Viral Characteristics: Small, double-stranded DNA virus (Papovaviridae family); infects squamous epithelial cells. Over 100 genotypes exist.
- Cancer Association: >80% of cervical cancers worldwide are linked to HPV, along with vaginal, vulval, penile, and anal carcinomas. HPV types 16 and 18 are particularly strongly associated with cervical cancer.
- Prevention: A quadrivalent vaccine is available, and cervical screening programs significantly reduce cervical cancer incidence.
- Hepatocellular Carcinoma (HCC): 81% of HCC cases are attributed to chronic infection. 75% of those with chronic HBV infection develop lifelong hepatic infection, leading to hepatocellular injury and chronic hepatitis.
- Risk Increase: Chronic HBV infection increases HCC risk 100-fold. Prevalence of HBV carriers is high in South East Asia, China, and sub-Saharan Africa (>20%).
- Treatment Advancements: Modern antiviral therapies can cure chronic infection, potentially drastically reducing future HCC incidence.
- Endemic Herpes Virus: A common herpes virus.
- Hodgkin's Lymphoma (HL): EBV is implicated in up to 60% of HL cases in developed countries and ≥80% in developing countries.
- Burkitt's Lymphoma (BL): EBV is considered causative in >90% of BL cases in equatorial Africa (where >90% of children are infected by age 3), but plays a lesser role elsewhere (<25% of cases). malaria is a suspected co-factor in bl development, potentially through b-cell stimulation or t-cell suppression.< />pan>
- Other Lymphomas and Nasopharyngeal Carcinoma: EBV's role in other non-Hodgkin's lymphomas (NHL) is less certain, but a strong link exists with nasopharyngeal carcinoma (EBV found in every anaplastic cell).
A. Helicobacter pylori:
- Gastric Cancer Association: Clearly linked to gastric adenocarcinoma; responsible for one-third (developed countries) to 50% (developing countries) of such cases. The exact carcinogenic mechanism is unclear.
- Gastric Lymphoma: H. pylori is also implicated in gastric lymphoma development. Different strains may vary in carcinogenic potential.
A. Schistosomiasis haematobium:
- Bladder Cancer: Associated with bladder hyperplasia, metaplasia, dysplasia, and invasive carcinoma. May account for 8% of bladder cancers in the developing world (mostly squamous cell), but is irrelevant in developed world cases.
- Geographic variation: Cancer rates linked to infection vary dramatically between developed and developing nations.
- Co-factors: Viral infections often require additional factors (genetic, environmental, immunological) to cause cancer.
- Latency: The time between infection and cancer development can be very long.
- Prevention and Treatment: Vaccines and antiviral therapies offer significant opportunities for cancer prevention and treatment.
- Fiber: The previously suggested link between high-fiber diets and reduced colon cancer risk might be confounded by factors like folate intake, and needs further confirmation.
- Fat: Research continues into how different dietary fats influence cancer risk, with saturated and trans fats (in meats and some dairy) being of particular concern.
- Specific Dietary Risk Factors: Dietary changes can significantly impact cancer incidence:
- Salt Fish: Reducing intake could reduce nasopharyngeal cancer by 33-50% in developing countries.
- Aflatoxins: (Mycotoxin found in contaminated food) Halving median daily intake could reduce HCC incidence by up to 40% in Africa and Asia.
- Inactivity & Cancer Risk: Physical inactivity increases the risk of many adult cancers, with the strongest evidence for breast and colon cancers.
- Benefits of Exercise: The benefits of increased exercise are independent of obesity. Exercise also improves outcomes and reduces recurrence rates in cancer patients (strongest evidence in breast cancer).
- Synergistic effects: Multiple risk factors multiply, rather than simply add to, the risk.
- Confounding factors: It is difficult to isolate the independent effect of one risk factor when others are also present (e.g., alcohol and smoking).
- Limited evidence: While many associations are noted, the mechanisms and strengths of the relationships are not always well-understood. More research is needed.
0 Comments
